← FDA ENFORCEMENT
D-0401-2026Class III

Radnostix

Recalling firm
Radnostix
Product type
Drug
Status
Ongoing
Report date
2026-04-01
Distribution
Nationwide in the US, including Puerto Rico
Firm state
ID
Product quantity
2,699 blister cartons
Initiated by
Voluntary: Firm initiated
Reason for recall

Failed Tablet/Capsule Specifications

Product description

Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, International Isotopes Inc., Idaho Falls, ID 83401. NDC: 69208-003-15; 69208-003-25; 69208-003-35

Code / lot info

Lot, expiry: Lot 3666245, exp: 02/28/2026; Lot 4546213, exp: 02/28/2026 and Lot 4951280, exp 09/30/2027

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.